AI Article Synopsis

  • The study identified a bacteria isolate, Bacillus subtilis K2, from moromi that shows strong proteolytic and fibrinolytic activity, suggesting potential health benefits.
  • BLASTn analysis revealed that the enzyme from B. subtilis K2 shares 73.6% similarity with a known fibrin-degrading enzyme, nattokinase, found in a Japanese soybean source.
  • Molecular docking analysis showed that the fibrinolytic enzyme, classified as a serine protease, has a high binding affinity for fibrin, indicating its potential use in treating thrombus diseases.

Article Abstract

The screening of proteolytic and fibrinolytic bacteria from moromi (an Indonesian soybean-based fermented food) yielded a number of isolates. Based on morphological and biochemical analyses and sequencing of the 16S rRNA gene, the isolate that exhibited the highest proteolytic and fibrinolytic activity was identified as Bacillus subtilis K2. The study was performed to analyze molecular characteristic of a fibrin-degrading enzyme from B. subtilis K2. BLASTn analysis of the nucleotide sequence encoding this fibrinolytic protein demonstrated 73.6% homology with the gene encoding the fibrin-degrading enzyme nattokinase of the B. subtilis subsp. natto, which was isolated from fermented soybean in Japan. An analysis of the putative amino-acid sequence of this protein indicated that it is a serine protease enzyme with aspartate, histidine, and serine in the catalytic triad. This enzyme was determined to be a 26-kDa molecule, as confirmed with a zymogram assay. Further bioinformatic analysis using Protparam demonstrated that the enzyme has a pI of 6.02, low instability index, high aliphatic index, and low GRAVY value. Molecular docking analysis using HADDOCK indicated that there are favorable interactions between subtilisin K2 and the fibrin substrate, as demonstrated by a high binding affinity (ΔG: - 19.4 kcal/mol) and low Kd value (6.3E-15 M). Overall, the study concluded that subtilisin K2 belong to serine protease enzyme has strong interactions with its fibrin substrate and fibrin can be rapidly degraded by this enzyme, suggesting its application as a treatment for thrombus diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11033-020-05898-2DOI Listing

Publication Analysis

Top Keywords

fibrin-degrading enzyme
12
enzyme
8
bacillus subtilis
8
indonesian soybean-based
8
soybean-based fermented
8
fermented food
8
proteolytic fibrinolytic
8
serine protease
8
protease enzyme
8
fibrin substrate
8

Similar Publications

At present, enzyme debridement preparation has shown a good curative effect on eschar removal of burn wounds. Keratinase has shown great potential in enzymatic debridement because of its good fibrin-degrading ability. In this study, the debridement of keratinase was examined by using a third degree burn wound model in rats.

View Article and Find Full Text PDF

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.

Cancers (Basel)

January 2022

Neoplastic Progression Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Several studies have ascertained that uPA and uPAR do participate in tumor progression and metastasis and are involved in cell adhesion, migration, invasion and survival, as well as angiogenesis. Increased levels of uPA and uPAR in tumor tissues, stroma and biological fluids correlate with adverse clinic-pathologic features and poor patient outcomes. After binding to uPAR, uPA activates plasminogen to plasmin, a broad-spectrum matrix- and fibrin-degrading enzyme able to facilitate tumor cell invasion and dissemination to distant sites.

View Article and Find Full Text PDF
Article Synopsis
  • The study identified a bacteria isolate, Bacillus subtilis K2, from moromi that shows strong proteolytic and fibrinolytic activity, suggesting potential health benefits.
  • BLASTn analysis revealed that the enzyme from B. subtilis K2 shares 73.6% similarity with a known fibrin-degrading enzyme, nattokinase, found in a Japanese soybean source.
  • Molecular docking analysis showed that the fibrinolytic enzyme, classified as a serine protease, has a high binding affinity for fibrin, indicating its potential use in treating thrombus diseases.
View Article and Find Full Text PDF

Background: Human tissue-type plasminogen activator (t-PA) is a key protease of the trypsin family. It catalyzes the activation of zymogen plasminogen to the fibrin-degrading proteinase, plasmin, leading to digestion of fibrin clots. The recombinant enzyme produced by recombinant technology issued to dissolve blood clots in treatment of various human diseases such as coronary artery thrombosis, pulmonary embolism, acute ischemic stroke (AIS).

View Article and Find Full Text PDF

Microbial production of nattokinase: current progress, challenge and prospect.

World J Microbiol Biotechnol

May 2017

Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, College of Life Sciences, Hubei University, 368 Youyi Avenue, Wuchang District, Wuhan, 430062, Hubei, People's Republic of China.

Nattokinase (EC 3.4.21.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!